NPs Basic Information
|
Name |
3-O-Methylfusarubin
|
| Molecular Formula | C15H14O6 | |
| IUPAC Name* |
5,8-dihydroxy-6-methoxy-2-methyl-3-(2-oxopropyl)naphthalene-1,4-dione
|
|
| SMILES |
COc1cc(O)c2c(c1O)C(=O)C(CC(C)=O)=C(C)C2=O
|
|
| InChI |
InChI=1S/C15H14O6/c1-6(16)4-8-7(2)13(18)11-9(17)5-10(21-3)15(20)12(11)14(8)19/h5,17,20H,4H2,1-3H3
|
|
| InChIKey |
UWONIGLSEZRPGH-UHFFFAOYSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
*Note: the IUPAC Name was calculated by STOUT. Reference: PMID:33906675.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 290.27 | ALogp: | 1.8 |
| HBD: | 2 | HBA: | 6 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 100.9 | Aromatic Rings: | 2 |
| Heavy Atoms: | 21 | QED Weighted: | 0.829 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -5.207 | MDCK Permeability: | 0.00000428 |
| Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.104 | 20% Bioavailability (F20%): | 0.051 |
| 30% Bioavailability (F30%): | 0.755 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.005 | Plasma Protein Binding (PPB): | 93.14% |
| Volume Distribution (VD): | 0.686 | Fu: | 13.44% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.928 | CYP1A2-substrate: | 0.854 |
| CYP2C19-inhibitor: | 0.022 | CYP2C19-substrate: | 0.063 |
| CYP2C9-inhibitor: | 0.204 | CYP2C9-substrate: | 0.63 |
| CYP2D6-inhibitor: | 0.269 | CYP2D6-substrate: | 0.179 |
| CYP3A4-inhibitor: | 0.063 | CYP3A4-substrate: | 0.09 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 4.241 | Half-life (T1/2): | 0.933 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.043 |
| Drug-inuced Liver Injury (DILI): | 0.793 | AMES Toxicity: | 0.692 |
| Rat Oral Acute Toxicity: | 0.051 | Maximum Recommended Daily Dose: | 0.477 |
| Skin Sensitization: | 0.915 | Carcinogencity: | 0.437 |
| Eye Corrosion: | 0.042 | Eye Irritation: | 0.888 |
| Respiratory Toxicity: | 0.496 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003141 |  |
0.766 | D01XWG |  |
0.295 | ||
| ENC006089 |  |
0.719 | D0N1FS |  |
0.280 | ||
| ENC005159 |  |
0.636 | D06GCK |  |
0.278 | ||
| ENC003531 |  |
0.569 | D0C9XJ |  |
0.278 | ||
| ENC000706 |  |
0.534 | D07VLY |  |
0.278 | ||
| ENC002239 |  |
0.534 | D07MGA |  |
0.275 | ||
| ENC006088 |  |
0.528 | D0WY9N |  |
0.254 | ||
| ENC000334 |  |
0.528 | D01XDL |  |
0.254 | ||
| ENC005550 |  |
0.506 | D0MM8N |  |
0.247 | ||
| ENC004459 |  |
0.500 | D0T5XN |  |
0.247 | ||